Despite this, we identified novel biomarkers of atherogenic dyslipidaemia in JSLE along with profound and highly significant alterations of lipoprotein metabolism associated with disease activity.
← all excerpts
Metabolomics Defines Complex Patterns of Dyslipidaemia in Juvenile-SLE Patients Associated with Inflammation and Potential Cardiovascular Disease Risk.
1
—
—